KMTS Earnings

KMTS reported its earnings on 2025-12-11, showcasing a revenue of 22.57M against an estimate of 21.22M, resulting in a 6.35% surprise. The EPS was -0.64, surpassing the expected -0.56 by -14.29%. The stock experienced a 5.06% price change on the earnings day and a 7.67% change over the next five days, reflecting market reactions to the results.

Following KMTS's earnings announcement on 2025-12-11, the stock price moved by 5.06% on the day of the release. Over the subsequent five days, it saw a 7.67% change. Historically, KMTS's stock price tends to shift by an average of 3.14% in the 10 days leading up to earnings and 11.03% in the 10 days following, providing insight into potential market.

For , analysts estimate KMTS's annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between KMTS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, KMTS's stock price typically moves by 3.14% in the 10 days before its earnings and 11.03% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .

The earnings call presents a mixed sentiment. While there is optimism with increased revenue guidance, gross margin expansion, and market growth, there are also concerns. The widening net loss and adjusted EBITDA loss, along with management's reluctance to provide specific guidance, could dampen investor sentiment. Additionally, the stock's reaction to strong gross margins and prescription growth suggests possible market skepticism. The Q&A insights highlight the company's strategic initiatives and market opportunities, but the financial uncertainties and competitive landscape may balance the positive aspects, resulting in a neutral outlook for the stock price.